pre-dose concentrations above LLOQ: useful topics [Bioanalytics]

posted by mittyri  – Russia, 2015-08-30 21:24 (3950 d 02:53 ago) – Posting: # 15364
Views: 5,922

Dear Mitesh,

I think you can find the answer in the following topics: here, here or here

In a nutshell:
EMA BE GL states:
Reanalysis of study samples should be predefined in the study protocol (and/or SOP) before the actual start of the analysis of the samples.

EMA bioanalytical method validation GL states that:
In case of reanalysis because of positive pre-dose samples or because of a pharmacokinetic reason, the reanalysed samples should be identified and the initial value, the reason for reanalysis, the values obtained in the reanalyses, the finally accepted value and a justification for the acceptance should be provided

Hope it helps

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
132 visitors (0 registered, 132 guests [including 32 identified bots]).
Forum time: 00:17 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5